GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Quotient Ltd (OTCPK:QTNTQ) » Definitions » Net Cash per Share

Quotient (Quotient) Net Cash per Share : $-78.38 (As of Dec. 2022)


View and export this data going back to 2014. Start your Free Trial

What is Quotient Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Quotient's Net Cash per Share for the quarter that ended in Dec. 2022 was $-78.38.

The historical rank and industry rank for Quotient's Net Cash per Share or its related term are showing as below:

QTNTQ's Price-to-Net-Cash is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 7.24
* Ranked among companies with meaningful Price-to-Net-Cash only.

Quotient Net Cash per Share Historical Data

The historical data trend for Quotient's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quotient Net Cash per Share Chart

Quotient Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -98.70 -49.31 -56.93 -56.77 -105.41

Quotient Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -89.98 -105.41 -81.67 -83.33 -78.38

Competitive Comparison of Quotient's Net Cash per Share

For the Medical Devices subindustry, Quotient's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quotient's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Quotient's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Quotient's Price-to-Net-Cash falls into.



Quotient Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Quotient's Net Cash per Share for the fiscal year that ended in Mar. 2022 is calculated as

Net Cash per Share (A: Mar. 2022 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(67.685-338.087-0)/2.56528
=-105.41

Quotient's Net Cash per Share for the quarter that ended in Dec. 2022 is calculated as

Net Cash per Share (Q: Dec. 2022 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(11.934-328.211-0)/4.03501
=-78.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quotient  (OTCPK:QTNTQ) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Quotient Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Quotient's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Quotient (Quotient) Business Description

Traded in Other Exchanges
N/A
Address
Business Park Terre Bonne, Route de Crassier 13, Eysins, CHE, 1262
Quotient Ltd is a commercial-stage diagnostics company. It is involved in the development, manufacturing, and commercialization of conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company develops and commercializes the Mosaiq automation platform. Its product portfolio includes Reagent Red Blood Cells, Antisera Products, Whole Blood Controls, and Ancillary Products. The firm operates in Edinburgh, Scotland, Eysins, Switzerland, and Newton, Pennsylvania. It derives the majority of its revenue from the United States.
Executives
Highbridge Capital Management Llc 10 percent owner 277 PARK AVE, 23RD FLOOR, NEW YORK NY 10172
Quotient Holdings Finance Co Ltd 10 percent owner C/O APPLEBY GLOBAL SERVICES (CAYMAN) LTD, 71 FORT STREET, PO BOX 500, GRAND CAYMAN E9 KY1-1106
Quotient Holdings Newco, Lp 10 percent owner C/O THE CORPORATION TRUST COMPANY, 1209 ORANGE STREET, WILMINGTON DE 19801
Quotient Holdings Merger Co Ltd 10 percent owner PO BOX 536, 13-14 ESPLANADE, ST. HELIER Y9 JE4 5UR
Quotient Holdings Gp, Llc 10 percent owner C/O THE CORPORATION TRUST COMPANY, 1209 ORANGE STREET, WILMINGTON DE 19801
Isabelle Buckle director C/O QUOTIENT LIMITED, B1, BUSINESS PARK, TERRE BONNE, ROUTE DE CRASSIER 13, EYSINS V8 1262
Prondzynski Heino Von director 275 NORTH FIELD DRIVE, LAKE FOREST IL 60045
Perceptive Life Sciences Master Fund Ltd 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Sophie Bechu director C/O QUOTIENT LIMITED, BUSINESS PARK TERRE BONNE, EYSINS V8 1262
Frederick Hallsworth director THE GARDEN WING, HOUSTON HOUSE, KIRK ROAD, HOUSTON X0 PA6 7AR
Manuel O. Mendez director, officer: Chief Executive Officer 500 PLAZA DRIVE, SECAUCUS NJ 07094
L John Wilkerson director, 10 percent owner C/O GALEN ASSOCIATES, 610 FIFTH AVENUE 5TH FLOOR, NEW YORK NY 10020
Zubeen Shroff director, 10 percent owner C/O HALSEY DRUG CO INC, 1827 PACIFIC STREET, BROOKLYN NY 11233
Ali Kiboro officer: Chief Financial Officer C/O QUOTIENT LIMITED, B1, BUSINESS PARK TERRE BONNE, EYSINS V8 1262
Brian Mcdonough director 12521 MARET DRIVE, ST. LOUIS MO 63127